214 related articles for article (PubMed ID: 30824278)
1. Treatment of refractory poor aPL-related obstetric outcomes with TNF-alpha blockers: Maternal-fetal outcomes in a series of 18 cases.
Alijotas-Reig J; Esteve-Valverde E; Llurba E; Gris JM
Semin Arthritis Rheum; 2019 Oct; 49(2):314-318. PubMed ID: 30824278
[TBL] [Abstract][Full Text] [Related]
2. Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies.
Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; LLurba E; Ruffatti A; Tincani A; Lefkou E; Bertero MT; Espinosa G; de Carolis S; Rovere-Querini P; Lundelin K; Picardo E; Mekinian A;
Med Clin (Barc); 2018 Sep; 151(6):215-222. PubMed ID: 29274674
[TBL] [Abstract][Full Text] [Related]
3. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases.
Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; Sáez-Comet L; Lefkou E; Mekinian A; Belizna C; Ruffatti A; Tincani A; Marozio L; Espinosa G; Cervera R; Ríos-Garcés R; De Carolis S; Latino O; LLurba E; Chighizola CB; Gerosa M; Pengo V; Lundelin K; Rovere-Querini P; Canti V; Mayer-Pickel K; Reshetnyak T; Hoxha A; Tabacco S; Stojanovich L; Gogou V; Varoudis A; Arnau A; Ruiz-Hidalgo D; Trapé J; Sos L; Stoppani C; Martí-Cañamares A; Farran-Codina I;
Autoimmun Rev; 2019 Apr; 18(4):406-414. PubMed ID: 30772493
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry.
Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; Sáez-Comet L; Lefkou E; Mekinian A; Belizna C; Ruffatti A; Hoxha A; Tincani A; Nalli C; Marozio L; Maina A; Espinosa G; Ríos-Garcés R; Cervera R; Carolis S; Monteleone G; Latino O; Udry S; LLurba E; Garrido-Gimenez C; Trespidi L; Gerosa M; Chighizola CB; Rovere-Querini P; Canti V; Mayer-Pickel K; Tabacco S; Arnau A; Trapé J; Ruiz-Hidalgo D; Sos L; Farran-Codina I;
Rheumatology (Oxford); 2020 Jun; 59(6):1306-1314. PubMed ID: 31580459
[TBL] [Abstract][Full Text] [Related]
5. Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases.
Khizroeva J; Bitsadze V; Tincani A; Makatsariya A; Arslanbekova M; Babaeva N; Tsibizova V; Shkoda A; Makatsariya N; Tretyakova M; Solopova A; Gadaeva Z; Vorobev A; Khamani I; Aslanova Z; Nakaidze I; Mischenko A; Grigoreva K; Kunesko N; Egorova E; Mashkova T
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6157-6164. PubMed ID: 34044735
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.
Fredi M; Andreoli L; Aggogeri E; Bettiga E; Lazzaroni MG; Le Guern V; Lojacono A; Morel N; Piette JC; Zatti S; Costedoat-Chalumeau N; Tincani A
Front Immunol; 2018; 9():864. PubMed ID: 29867924
[TBL] [Abstract][Full Text] [Related]
7. Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort.
Alijotas-Reig J; Ferrer-Oliveras R; Esteve-Valverde E; Ruffatti A; Tincani A; Lefkou E; Bertero MT; Espinosa G; Coloma E; de Carolis S; Rovere-Querini P; Canti V; Picardo E; Fredi M; Mekinian A;
Am J Reprod Immunol; 2016 Aug; 76(2):164-71. PubMed ID: 27401589
[TBL] [Abstract][Full Text] [Related]
8. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
Lefkou E; Varoudi K; Pombo J; Jurisic A; Jurisic Z; Contento G; Girardi G
Biochem Pharmacol; 2020 Dec; 182():114217. PubMed ID: 32926874
[TBL] [Abstract][Full Text] [Related]
9. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases.
Alijotas-Reig J; Ferrer-Oliveras R; Ruffatti A; Tincani A; Lefkou E; Bertero MT; Coloma-Bazan E; de Carolis S; Espinosa G; Rovere-Querini P; Kuzenko A; Valverde EE; Robles A; Cervera R; Canti V; Fredi M; Gil-Aguado A; Lundelin K; Llurba E; Melnychuk T; Nalli C; Picardo E; Silvestro E; del Ross T; Farran-Codina I;
Autoimmun Rev; 2015 May; 14(5):387-95. PubMed ID: 25555817
[TBL] [Abstract][Full Text] [Related]
10. Bleeding and antithrombotic therapy during pregnancy in women with poor aPL-related obstetric outcomes: A survey of 1075 cases from EUROAPS registry∗.
Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; Sáez-Comet L; Lefkou E; Mekinian A; Belizna C; Ruffatti A; Tincani A; Pardos-Gea J; Nalli C; Marozio L; Espinosa G; De Carolis S; Latino O; Sebastian U; LLurba E; Trespidi L; Chighizola C; Pengo V; Rovere-Querini P; Canti V; Mayer-Pickel K; Reshetnyak T; Tabacco S; Arnau A;
Eur J Anaesthesiol; 2021 Sep; 38(9):916-922. PubMed ID: 34397526
[TBL] [Abstract][Full Text] [Related]
11. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a preliminary first year report.
Alijotas-Reig J; Ferrer-Oliveras R;
Lupus; 2012 Jun; 21(7):766-8. PubMed ID: 22635227
[TBL] [Abstract][Full Text] [Related]
12. [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL].
Mekinian A; Vicaut E; Cohen J; Bornes M; Kayem G; Fain O
Gynecol Obstet Fertil Senol; 2018; 46(7-8):598-604. PubMed ID: 30041771
[TBL] [Abstract][Full Text] [Related]
13. Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.
Del Ross T; Ruffatti A; Visentin MS; Tonello M; Calligaro A; Favaro M; Hoxha A; Punzi L
J Rheumatol; 2013 Apr; 40(4):425-9. PubMed ID: 23418380
[TBL] [Abstract][Full Text] [Related]
14. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome.
Gerde M; Ibarra E; Mac Kenzie R; Fernandez Suarez C; Heer C; Alvarez R; Iglesias M; Balparda J; Beruti E; Rubinstein F
Thromb Res; 2021 Oct; 206():104-110. PubMed ID: 34454240
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M
Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067
[TBL] [Abstract][Full Text] [Related]
16. Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.
Lazzaroni MG; Fredi M; Andreoli L; Chighizola CB; Del Ross T; Gerosa M; Kuzenko A; Raimondo MG; Lojacono A; Ramazzotto F; Zatti S; Trespidi L; Meroni PL; Pengo V; Ruffatti A; Tincani A
Front Immunol; 2019; 10():1948. PubMed ID: 31475009
[No Abstract] [Full Text] [Related]
17. [Clinical characteristics and pregnancy outcomes of non-criteria obstetric antiphospholipid syndrome].
Yang XX; Sun YD; Zhao JL; Tian XP; Zeng XF; Li MT
Zhonghua Nei Ke Za Zhi; 2021 Sep; 60(9):812-816. PubMed ID: 34445817
[No Abstract] [Full Text] [Related]
18. Hydroxychloroquine and antiphospholipid antibody-related pregnancy morbidity: a systematic review and meta-analysis.
Frishman M; Radin M; Schreiber K
Curr Opin Obstet Gynecol; 2020 Oct; 32(5):351-358. PubMed ID: 32675702
[TBL] [Abstract][Full Text] [Related]
19. Clinical features associated with pregnancy outcomes in women with positive antiphospholipid antibodies and previous adverse pregnancy outcomes: a real-world prospective study.
Li X; Deng X; Duan H; Zeng L; Zhou J; Liu C; Guo X; Liu X
Clin Rheumatol; 2021 Jan; 40(1):193-204. PubMed ID: 32514680
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment.
Sciascia S; Branch DW; Levy RA; Middeldorp S; Pavord S; Roccatello D; Ruiz-Irastorza G; Tincani A; Khamashta M; Schreiber K; Hunt BJ
Thromb Haemost; 2016 Jan; 115(2):285-90. PubMed ID: 26421409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
